Translational Development Acqui
TDACU
Last
$11.66
Day
-5.0%
1y
+15.2%
5y
+22.3%
52w
-52.2%
SPY YTD
+13.3%
XLF
-1.3%
Earnings
—
EMA 21
11.86
EMA 50
11.42
EMA 200
11.63
20d high
-25.1%
5y high
-52.2%
5y range
15th
Positions held
Your positionsTDACU isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
53
Hold
swing
Signal
Strong Buy
Target
$12.98
Stop
$11.68
Stop distance
0.2%
Target vs last
+11.3%
Fundamentals
| Market cap | — | Enterprise value | $237.93M | Trailing P/E | — | Forward P/E | — |
| PEG | — | Price / book | -30.83 | Beta | — | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | -40.6% | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | — | ROA | -0.5% | Debt / equity | — |
| Current ratio | 0.06 | Free cash flow | -$355,048 | Analyst recommendation | none | Mean target | — |
| 52w high | $17.29 | 52w low | $10.44 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — | — |
| Net income | $0.9M | $1.3M | $1.6M | $1.7M | $1.6M | — |
| Gross margin | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$0.7M | -$0.3M | -$0.2M | -$0.2M | -$0.2M | — |
Yearly (6y)
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M |
| Op margin | — | — | — |
| Net income | $6.4M | -$0.1M | -$0.5M |
| Gross margin | — | — | — |
| Gross profit | — | — | — |
| Operating income | -$0.9M | -$0.2M | -$0.5M |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
Price (daily)
Full chart · RSI · MACD · patternsTDACU · daily+2.3% over 11 sessions
Close EMA21 EMA50 EMA200
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin